The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very

C Bührer1, I Grimmer, B Metze

  • 1Department of Neonatology, Charité-Virchow Hospital, Humboldt University, Berlin, Germany. christoph.buehrer@charite.de

Insights

The Clinical Risk Index for Babies (CRIB) score shows an association with neurodevelopmental impairment in very low birth weight (VLBW) infants. However, its predictive value is limited for clinical stratification or hospital comparisons.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Clinical Risk Assessment

Background:

  • Very low birth weight (VLBW) infants are at high risk for adverse neurodevelopmental outcomes.
  • Accurate prediction of neurodevelopmental impairment (NDI) is crucial for early intervention and resource allocation.
  • The Clinical Risk Index for Babies (CRIB) is a commonly used scoring system for assessing neonatal risk.

Purpose of the Study:

  • To evaluate the predictive ability of the CRIB score for long-term neurodevelopmental impairment in VLBW infants.
  • To determine if CRIB scores can effectively stratify VLBW infants for clinical trials or hospital performance comparisons.

Main Methods:

  • A single-center cohort study included 455 VLBW infants admitted between 1992 and 1997.
  • CRIB scores were calculated using parameters such as birth weight, gestational age, and oxygen requirements.
  • Neurodevelopmental assessment at 1 year corrected age was performed using the Griffiths scales of mental development.

Main Results:

  • Major neurodevelopmental impairment was observed in 22% of the 352 infants assessed.
  • CRIB scores and specific components (e.g., maximum fraction of inspired oxygen) were independently associated with NDI.
  • The predictive performance of the CRIB score for NDI was comparable to birth weight alone.

Conclusions:

  • High CRIB scores are associated with an increased risk of major neurodevelopmental impairment in VLBW infants.
  • The CRIB score has limited utility for stratifying infants in randomized trials or for adjusting performance metrics between hospitals when NDI is the primary outcome.
Abstract